Literature DB >> 35000722

The Next Challenge for Post-COVID-19 Clinics: Scale.

Eunice Yu1, Bryan Kelly2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35000722      PMCID: PMC8733310          DOI: 10.1016/j.chest.2021.07.045

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
To the Editor: We read with great interest the review by Santosh et al published in CHEST (August 2021) regarding emerging clinic designs for patients who experience post-acute sequelae of COVID-19 (PASC). We suggest a focus on centering resources in primary care. Many PASC clinics have significant access issues because of limited resources for this growing population that often requires high-touch and accessible care. To manage volume, many clinics exclude patients based on severity of their initial COVID-19 infection. Although PASC is more likely in the hospitalized population, stratification of ambulatory care resources by such history may be inappropriate.3, 4, 5 Additionally, although streamlined access to specialty care is essential, a separate clinic often leads to care happening in parallel to the primary care relationship. We propose an alternative strategy that may be more scalable and adaptable. First, train primary care clinicians in the fundamentals of PASC care. Second, provide a mechanism to engage additional support with a low barrier of entry and quick turnaround. We use “e-consults,” an electronic chart message sent to a pool of internists with a special interest in PASC, to answer questions that arise. Our team uses standardized assessments and care pathways when responding, which allows us to comanage mild-to-moderate presentations. Finally, complex patients who are identified by e-consult are triaged to a multidisciplinary case conference that regularly reviews cases in “tumor-board”-style to coordinate care, expedite specialty evaluation if needed, and develop comprehensive care plans. This approach scales quickly and meets the framework proposed by Santosh et al. We hope to spark additional innovation in the care of this growing population.
  4 in total

1.  Attributes and predictors of long COVID.

Authors:  Sebastien Ourselin; Tim Spector; Claire J Steves; Carole H Sudre; Benjamin Murray; Thomas Varsavsky; Mark S Graham; Rose S Penfold; Ruth C Bowyer; Joan Capdevila Pujol; Kerstin Klaser; Michela Antonelli; Liane S Canas; Erika Molteni; Marc Modat; M Jorge Cardoso; Anna May; Sajaysurya Ganesh; Richard Davies; Long H Nguyen; David A Drew; Christina M Astley; Amit D Joshi; Jordi Merino; Neli Tsereteli; Tove Fall; Maria F Gomez; Emma L Duncan; Cristina Menni; Frances M K Williams; Paul W Franks; Andrew T Chan; Jonathan Wolf
Journal:  Nat Med       Date:  2021-03-10       Impact factor: 53.440

2.  Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.

Authors:  Jana L Hirschtick; Andrea R Titus; Elizabeth Slocum; Laura E Power; Robert E Hirschtick; Michael R Elliott; Patricia McKane; Nancy L Fleischer
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.

Authors:  Sarah E Daugherty; Yinglong Guo; Kevin Heath; Micah C Dasmariñas; Karol Giuseppe Jubilo; Jirapat Samranvedhya; Marc Lipsitch; Ken Cohen
Journal:  BMJ       Date:  2021-05-19

Review 4.  Rapid Design and Implementation of Post-COVID-19 Clinics.

Authors:  Lekshmi Santhosh; Brian Block; Soo Yeon Kim; Sarath Raju; Rupal J Shah; Neeta Thakur; Emily Pfeil Brigham; Ann Marie Parker
Journal:  Chest       Date:  2021-03-31       Impact factor: 10.262

  4 in total
  1 in total

Review 1.  Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Aluko A Hope; Teresa H Evering
Journal:  Infect Dis Clin North Am       Date:  2022-02-15       Impact factor: 5.905

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.